Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

MiStent Data the Subject of Three EuroPCR 2017 Presentations PARIS, May 16, 2017 -- (Healthcare Sales & Marketing Network) -- Micell Technologies announced today at the late-breaking trial session of EuroPCR – the official congress of the European Asso... Devices, Interventional, Cardiology Micell Technologies, DESSOLVE III, MiStent, Sirolimus, drug eluting stent
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news